AK-FLUOR 10% Drug Patent Profile
✉ Email this page to a colleague
When do Ak-fluor 10% patents expire, and what generic alternatives are available?
Ak-fluor 10% is a drug marketed by Long Grove Pharms and is included in one NDA.
The generic ingredient in AK-FLUOR 10% is fluorescein sodium. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ak-fluor 10%
A generic version of AK-FLUOR 10% was approved as fluorescein sodium by NEXUS PHARMS on September 25th, 2023.
Summary for AK-FLUOR 10%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AK-FLUOR 10% at DailyMed |
Pharmacology for AK-FLUOR 10%
| Drug Class | Diagnostic Dye |
| Mechanism of Action | Dyes |
Anatomical Therapeutic Chemical (ATC) Classes for AK-FLUOR 10%
US Patents and Regulatory Information for AK-FLUOR 10%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long Grove Pharms | AK-FLUOR 10% | fluorescein sodium | INJECTABLE;INTRAVENOUS | 022186-001 | Aug 8, 2008 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
